Abstract
Objective: To review recent epidemiologic studies of vaccination and melanoma risk as well as critically discuss the different melanoma vaccines under investigation in multicenter phase III melanoma vaccine trials. Data Sources: A retrospective review of the literature. Study Selection: Studies included those on the risk of melanoma and vaccination, historically relevant data, and ongoing or recently published phase III melanoma vaccine trials. The referenced study designs and methodologies varied. Data extraction and Synthesis: 3 reviewers extracted Data and the main results are presented in a quantitative descriptive manner. Conclusion: Vaccine therapy of melanoma remains promising, given the associated low toxicity. Epidemiologic studies suggest a role for vaccines against certain infectious diseases in melanoma prevention. While results of ongoing phase III melanoma vaccines trials may open new avenues for disease prevention, a better understanding of immune responses to melanoma vaccines will be necessary.
Keywords: immunosuppression, bacille calmette-guerin (bcg), fibrosarcoma, t-lymphocytes, melanoma vaccines, immune system, adjuvant chemotherapy, delayed-type hypersensitivity (dth), viral oncolysates
Current Cancer Therapy Reviews
Title: Vaccine Therapy of Melanoma: An Update
Volume: 1 Issue: 2
Author(s): Marie-France Demierre, Susan M. Swetter and Vernon K. Sondak
Affiliation:
Keywords: immunosuppression, bacille calmette-guerin (bcg), fibrosarcoma, t-lymphocytes, melanoma vaccines, immune system, adjuvant chemotherapy, delayed-type hypersensitivity (dth), viral oncolysates
Abstract: Objective: To review recent epidemiologic studies of vaccination and melanoma risk as well as critically discuss the different melanoma vaccines under investigation in multicenter phase III melanoma vaccine trials. Data Sources: A retrospective review of the literature. Study Selection: Studies included those on the risk of melanoma and vaccination, historically relevant data, and ongoing or recently published phase III melanoma vaccine trials. The referenced study designs and methodologies varied. Data extraction and Synthesis: 3 reviewers extracted Data and the main results are presented in a quantitative descriptive manner. Conclusion: Vaccine therapy of melanoma remains promising, given the associated low toxicity. Epidemiologic studies suggest a role for vaccines against certain infectious diseases in melanoma prevention. While results of ongoing phase III melanoma vaccines trials may open new avenues for disease prevention, a better understanding of immune responses to melanoma vaccines will be necessary.
Export Options
About this article
Cite this article as:
Demierre Marie-France, Swetter M. Susan and Sondak K. Vernon, Vaccine Therapy of Melanoma: An Update, Current Cancer Therapy Reviews 2005; 1 (2) . https://dx.doi.org/10.2174/1573394054021718
DOI https://dx.doi.org/10.2174/1573394054021718 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antigenic Peptide Vaccination: Provoking Immune Response and Clinical Benefit for Cancer
Current Immunology Reviews (Discontinued) Biological Effects of Curcumin and Its Role in Cancer Chemoprevention and Therapy
Anti-Cancer Agents in Medicinal Chemistry Vitamin D and Breast Cancer Incidence and Outcome
Anti-Cancer Agents in Medicinal Chemistry GDF 15 - A Novel Biomarker in the Offing for Heart Failure
Current Cardiology Reviews Current Status of Leukemia Cytotherapy - Exploitation with Immune Cells
Current Stem Cell Research & Therapy Ellagic Acid Enhances the Efficacy of PI3K Inhibitor GDC-0941 in Breast Cancer Cells
Current Molecular Medicine Repurposing Drugs for Cancer Prevention
Current Topics in Medicinal Chemistry Heat Shock Protein 70s as Potential Molecular Targets for Colon Cancer Therapeutics
Current Medicinal Chemistry Wnt/beta-Catenin Signaling and Small Molecule Inhibitors
Current Pharmaceutical Design Recombinant Human Insulin-Like Growth Factor-1: A New Cardiovascular Disease Treatment Option?
Cardiovascular & Hematological Agents in Medicinal Chemistry Intramolecular Processes and Their Applications in Prodrugs Approaches- Experimental and Computational Studies
Current Organic Chemistry The State-of-Art in Angiogenic Properties of Latex from Different Plant Species
Current Angiogenesis (Discontinued) Current Perspectives on the Role of Nrf2 in 5-Fluorouracil Resistance in Colorectal Cancer
Anti-Cancer Agents in Medicinal Chemistry From Test Tube to Clinical Trial; Promising Herbs with NF-κB and COX- 2 Activity
Current Immunology Reviews (Discontinued) Tumoral Drug Metabolism: Perspectives and Therapeutic Implications
Current Drug Metabolism Combination of Photodynamic Therapy with Anti-Cancer Agents
Current Medicinal Chemistry The Minority Aging Research Study: Ongoing Efforts to Obtain Brain Donation in African Americans without Dementia
Current Alzheimer Research Cells Under Pressure – Treatment of Eukaryotic Cells with High Hydrostatic Pressure, from Physiologic Aspects to Pressure Induced Cell Death
Current Medicinal Chemistry Heat Shock Protein 90 Inhibitors as Broad Spectrum Anti-Infectives
Current Pharmaceutical Design Vitamin D and Asthma: Scientific Promise and Clinical Reality
Current Respiratory Medicine Reviews